NeuroSense Therapeutics Ltd. Increase (Decrease) in Other Accounts Payable
NeuroSense Therapeutics Ltd. (NRSN) reported Increase (Decrease) in Other Accounts Payable of $1.27 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-03-31
| Period end | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|
| 2025-12-31 | $1.27M 20-F · filed 2026-03-31 | |
| 2025-06-30 | $312.00K 6-K · filed 2025-08-01 | |
| 2024-12-31 | $262.00K 20-F · filed 2026-03-31 | |
| 2024-06-30 | $25.00K 6-K · filed 2025-08-01 | |
| 2023-12-31 | $928.00K 20-F · filed 2026-03-31 | |
| 2023-06-30 | $846.00K 6-K · filed 2024-09-30 | |
| 2022-12-31 | $606.00K 20-F · filed 2025-04-07 | |
| 2021-12-31 | $493.00K 6-K · filed 2024-06-17 |